SML0408
羧酰氨基三唑
≥98% (HPLC)
别名:
5-氨基-1-(3,5-二氯-4-(4-氯苯甲酰基)苄基甲基)-1H-1,2,3-三氮唑-4-羧酰胺, CAI, L-651582
登录查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C17H12Cl3N5O2
化学文摘社编号:
分子量:
424.67
MDL编号:
UNSPSC代码:
12352200
PubChem化学物质编号:
NACRES:
NA.77
质量水平
方案
≥98% (HPLC)
表单
powder
颜色
white to beige
溶解性
DMSO: 10 mg/mL (clear solution)
储存温度
2-8°C
SMILES字符串
NC(=O)c1nnn(Cc2cc(Cl)c(c(Cl)c2)C(=O)c3ccc(Cl)cc3)c1N
InChI
1S/C17H12Cl3N5O2/c18-10-3-1-9(2-4-10)15(26)13-11(19)5-8(6-12(13)20)7-25-16(21)14(17(22)27)23-24-25/h1-6H,7,21H2,(H2,22,27)
InChI key
WNRZHQBJSXRYJK-UHFFFAOYSA-N
相关类别
生化/生理作用
羧胺三唑（CAI）是一种没有细胞毒性的抗癌药物。它具有抗炎特性，并减少促炎细胞因子的释放。CAI可以在体外和体内阻止多种人类癌细胞和内皮细胞的增殖和侵袭行为。它可用于治疗多种急性和慢性炎症模型，如佐剂性关节炎和炎症性肠病（IBD）。CAI在体外阻断肿瘤细胞增殖并刺激细胞凋亡。
羧酰氨基三唑是一种钙通道阻滞剂/钙通量抑制剂；阻断 CRAC 通道功能。
羧酰氨基三唑（L-651582）是一种口服活性钙通道阻滞剂。羧酰氨基三唑阻断细胞内和线粒体钙的进入和通量，从而抑制细胞增殖、激活钙释放激活的钙通道（CRAC）功能并维持线粒体膜电位。
警示用语：
Danger
危险声明
危险分类
Acute Tox. 3 Oral
储存分类代码
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
Hui Song et al.
Frontiers in microbiology, 8, 1419-1419 (2017-08-12)
Codon usage bias plays an important role in shaping genomes and genes in unicellular species and multicellular species. Here, we first analyzed codon usage bias in seven
Kevin Deschamps et al.
Clinical biomechanics (Bristol, Avon), 54, 1-7 (2018-03-05)
Investigate differences in multi-segment foot kinematics between controls and participants with chronic ankle instability during running with a midfoot striking pattern and to evaluate the effect of Low-Dye and High-Dye taping. Three-dimensional multi-segment foot kinematics of 12 controls and 15
Lars P J Cruysberg et al.
Retina (Philadelphia, Pa.), 25(8), 1022-1031 (2005-12-13)
To evaluate the human transscleral diffusion and intravitreal delivery of carboxyamido-triazole (CAI) and 2-Methoxyestradiol (2ME2). The transscleral diffusion of two retinal antiangiogenic molecules, CAI and 2ME2, was measured in vitro to assess their potential transscleral delivery. Varying concentrations and different
Andreia S P Sousa et al.
Scientific reports, 9(1), 3115-3115 (2019-03-01)
This study aims to: (1) to compare 2 methods of assessing the timing of medium latency responses (MLR), in regard to intrasession reliability and mean values, in subjects with and without chronic ankle instability (CAI), and (2) to analyze the
Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
Lei Guo et al.
European journal of pharmacology, 746, 14-21 (2014-12-03)
Carboxyamidotriazole (CAI) is a non-cytotoxic anti-tumor drug, which also shows considerable anti-inflammatory effects in a variety of animal models of inflammation. The exact target and mechanism of CAI were not clearly understood yet. In the present study, we demonstrate that
商品
We offers many products related to calcium channels for your research needs.
我们提供多种与钙通道相关的产品以满足您的各类研究需求。
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持